$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 12/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 12/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 79.69 | 1,537 | 122,484 | 55,033 | 56.6 K to 55 K (-2.72 %) |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 109,000 | |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,000 | 17,860 | 10,000 | |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 288,031 | 287 K to 288 K (+0.35 %) |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,000 | 17,860 | 287,031 | 286 K to 287 K (+0.35 %) |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 110,000 | |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 111,000 | |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 286,031 | 285 K to 286 K (+0.35 %) |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 285,031 | 284 K to 285 K (+0.35 %) |
Mar 27 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 81.35 | 3,350 | 272,523 | 87,989 | 91.3 K to 88 K (-3.67 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 81.36 | 3,486 | 283,621 | 84,459 | 87.9 K to 84.5 K (-3.96 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 81.36 | 3,583 | 291,513 | 56,570 | 60.2 K to 56.6 K (-5.96 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 112,000 | |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 81.36 | 13,075 | 1,063,782 | 284,031 | 297.1 K to 284 K (-4.40 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 297,106 | 296.1 K to 297.1 K (+0.34 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 81.36 | 3,583 | 291,513 | 73,602 | 77.2 K to 73.6 K (-4.64 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Payment of Exercise | F | 81.36 | 414 | 33,683 | 17,559 | 18 K to 17.6 K (-2.30 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 81.36 | 5,812 | 472,864 | 156,676 | 162.5 K to 156.7 K (-3.58 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 81.36 | 3,295 | 268,081 | 91,339 | 94.6 K to 91.3 K (-3.48 %) |